• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响社区药房服务实施的障碍与促进因素的定性元综合研究:患者、护士及全科医生的观点

Qualitative meta-synthesis of barriers and facilitators that influence the implementation of community pharmacy services: perspectives of patients, nurses and general medical practitioners.

作者信息

Hossain Lutfun N, Fernandez-Llimos Fernando, Luckett Tim, Moullin Joanna C, Durks Desire, Franco-Trigo Lucia, Benrimoj Shalom I, Sabater-Hernández Daniel

机构信息

Graduate School of Health, University of Technology, Sydney, New South Wales, Australia.

Department of Social Pharmacy, Faculty of Pharmacy, Research Institute for Medicines, University of Lisbon, Lisboa, Portugal.

出版信息

BMJ Open. 2017 Sep 5;7(9):e015471. doi: 10.1136/bmjopen-2016-015471.

DOI:10.1136/bmjopen-2016-015471
PMID:28877940
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5588935/
Abstract

OBJECTIVES

The integration of community pharmacy services (CPSs) into primary care practice can be enhanced by assessing (and further addressing) the elements that enable (ie, facilitators) or hinder (ie, barriers) the implementation of such CPSs. These elements have been widely researched from the perspective of pharmacists but not from the perspectives of other stakeholders who can interact with and influence the implementation of CPSs. The aim of this study was to synthesise the literature on patients', general practitioners' (GPs) and nurses' perspectives of CPSs to identify barriers and facilitators to their implementation in Australia.

METHODS

A meta-synthesis of qualitative studies was performed. A systematic search in PubMed, Scopus and Informit was conducted to identify studies that explored patients', GPs' or nurses' views about CPSs in Australia. Thematic synthesis was performed to identify elements influencing CPS implementation, which were further classified using an ecological approach.

RESULTS

Twenty-nine articles were included in the review, addressing 63 elements influencing CPS implementation. Elements were identified as a barrier, facilitator or both and were related to four ecological levels: individual patient (n=14), interpersonal (n=24), organisational (n=16) and community and healthcare system (n=9). It was found that patients, nurses and GPs identified elements reported in previous pharmacist-informed studies, such as pharmacist's training/education or financial remuneration, but also new elements, such as patients' capability to follow service's procedures, the relationships between GP and pharmacy professional bodies or the availability of multidisciplinary training/education.

CONCLUSIONS

Patients, GPs and nurses can describe a large number of elements influencing CPS implementation. These elements can be combined with previous findings in pharmacists-informed studies to produce a comprehensive framework to assess barriers and facilitators to CPS implementation. This framework can be used by pharmacy service planners and policy makers to improve the analysis of the contexts in which CPSs are implemented.

摘要

目的

通过评估(并进一步解决)促进(即推动因素)或阻碍(即障碍因素)社区药房服务(CPS)实施的因素,可加强社区药房服务与初级医疗实践的整合。这些因素已从药剂师的角度进行了广泛研究,但尚未从其他能够与CPS实施进行互动并影响其实施的利益相关者的角度进行研究。本研究的目的是综合关于患者、全科医生(GP)和护士对CPS看法的文献,以确定在澳大利亚实施CPS的障碍和促进因素。

方法

对定性研究进行元综合分析。在PubMed、Scopus和Informit中进行系统检索,以识别探讨澳大利亚患者、全科医生或护士对CPS看法的研究。进行主题综合分析以确定影响CPS实施的因素,并使用生态方法进一步分类。

结果

该综述纳入了29篇文章,涉及影响CPS实施的63个因素。这些因素被确定为障碍、促进因素或两者兼具,并与四个生态层面相关:个体患者(n = 14)、人际层面(n = 24)、组织层面(n = 16)以及社区和医疗保健系统层面(n = 9)。研究发现,患者、护士和全科医生识别出了先前药剂师主导研究中报告的因素,如药剂师的培训/教育或经济报酬,但也发现了新的因素,如患者遵循服务程序的能力、全科医生与药房专业机构之间的关系或多学科培训/教育的可获得性。

结论

患者、全科医生和护士能够描述大量影响CPS实施的因素。这些因素可与先前药剂师主导研究的结果相结合,以形成一个全面的框架,用于评估CPS实施的障碍和促进因素。该框架可供药房服务规划者和政策制定者用于改进对CPS实施背景的分析。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6bd/5588935/6aa4ab9ae490/bmjopen-2016-015471f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6bd/5588935/6aa4ab9ae490/bmjopen-2016-015471f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6bd/5588935/6aa4ab9ae490/bmjopen-2016-015471f01.jpg

相似文献

1
Qualitative meta-synthesis of barriers and facilitators that influence the implementation of community pharmacy services: perspectives of patients, nurses and general medical practitioners.影响社区药房服务实施的障碍与促进因素的定性元综合研究:患者、护士及全科医生的观点
BMJ Open. 2017 Sep 5;7(9):e015471. doi: 10.1136/bmjopen-2016-015471.
2
Solidarity or dissonance? A systematic review of pharmacist and GP views on community pharmacy services in the UK.团结还是不和谐?对英国社区药剂师和全科医生对社区药房服务看法的系统评价。
Health Soc Care Community. 2019 May;27(3):565-598. doi: 10.1111/hsc.12618. Epub 2018 Jul 26.
3
A multilevel stakeholder approach for identifying the determinants of implementation of government-funded community pharmacy services at the primary care level.采用多层次利益相关者方法确定初级保健层面实施政府资助社区药房服务的决定因素。
Res Social Adm Pharm. 2018 Aug;14(8):765-775. doi: 10.1016/j.sapharm.2017.10.001. Epub 2017 Oct 5.
4
Stakeholder analysis for the development of a community pharmacy service aimed at preventing cardiovascular disease.利益相关者分析,旨在预防心血管疾病的社区药房服务的发展。
Res Social Adm Pharm. 2017 May-Jun;13(3):539-552. doi: 10.1016/j.sapharm.2016.06.009. Epub 2016 Jun 30.
5
Community pharmacy integration within the primary care pathway for people with long-term conditions: a focus group study of patients', pharmacists' and GPs' experiences and expectations.社区药房整合到慢性病患者的初级保健途径中:一项对患者、药剂师和全科医生的经验和期望的焦点小组研究。
BMC Fam Pract. 2019 Feb 8;20(1):26. doi: 10.1186/s12875-019-0912-0.
6
Barriers and facilitators for the implementation of the CombiConsultation by general practitioners, pharmacists and practice nurses: a qualitative interview study.全科医生、药剂师和执业护士实施 CombiConsultation 的障碍和促进因素:定性访谈研究。
Int J Clin Pharm. 2023 Aug;45(4):970-979. doi: 10.1007/s11096-023-01597-7. Epub 2023 May 30.
7
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.超越黑木树:影响澳大利亚地区、农村和偏远地区的健康研究问题的快速综述。
Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881.
8
Stakeholders' perspectives and experiences of the pharmacist's role in deprescribing in ambulatory care: A qualitative meta-synthesis.利益相关者对药师在门诊照护中减少药物使用角色的看法和经验:定性元分析。
Res Social Adm Pharm. 2024 Aug;20(8):697-712. doi: 10.1016/j.sapharm.2024.04.014. Epub 2024 Apr 27.
9
A mixed methods analysis of community pharmacists' perspectives on delivering COPD screening service to guide future implementation.社区药剂师对提供 COPD 筛查服务的看法的混合方法分析,以指导未来的实施。
Res Social Adm Pharm. 2019 Jun;15(6):662-672. doi: 10.1016/j.sapharm.2018.08.007. Epub 2018 Aug 14.
10
Pharmacist and physician perspectives on diabetes service delivery within community pharmacies in Indonesia: a qualitative study.印度尼西亚社区药房糖尿病服务提供的药剂师与医生观点:一项定性研究
Int J Pharm Pract. 2016 May;24(3):180-8. doi: 10.1111/ijpp.12227. Epub 2015 Dec 16.

引用本文的文献

1
Attitudes and expectations toward medication review among community pharmacy customers in Germany: a cross-sectional study.德国社区药房顾客对用药评估的态度和期望:一项横断面研究。
J Pharm Policy Pract. 2025 Apr 25;18(1):2490572. doi: 10.1080/20523211.2025.2490572. eCollection 2025.
2
Factors affecting community pharmacists' capacity to deliver pharmacy services in Zhengzhou, China: a cross-sectional study.影响中国郑州社区药剂师提供药学服务能力的因素:一项横断面研究。
BMJ Open. 2024 Oct 29;14(10):e083104. doi: 10.1136/bmjopen-2023-083104.
3
Investigation on pharmaceutical care barriers perceived by clinical pharmacists in secondary and tertiary hospitals in China.

本文引用的文献

1
Use of Intervention Mapping to Enhance Health Care Professional Practice: A Systematic Review.运用干预映射增强医疗保健专业实践:系统评价。
Health Educ Behav. 2017 Aug;44(4):524-535. doi: 10.1177/1090198117709885. Epub 2017 Jun 3.
2
A qualitative study exploring physicians' perceptions on the role of community pharmacists in Dubai.一项探索医生对迪拜社区药剂师角色看法的定性研究。
Pharm Pract (Granada). 2016 Jul-Sep;14(3):738. doi: 10.18549/PharmPract.2016.03.738. Epub 2016 Sep 15.
3
Stakeholder analysis for the development of a community pharmacy service aimed at preventing cardiovascular disease.
中国二级和三级医院临床药师感知到的药学服务障碍调查。
Heliyon. 2024 Jul 26;10(19):e35192. doi: 10.1016/j.heliyon.2024.e35192. eCollection 2024 Oct 15.
4
Patient medication management, understanding and adherence during the transition from hospital to outpatient care - a qualitative longitudinal study in polymorbid patients with type 2 diabetes.患者的药物管理、从住院过渡到门诊护理期间的理解和依从性 - 2 型糖尿病合并多种疾病患者的定性纵向研究。
BMC Health Serv Res. 2024 May 13;24(1):620. doi: 10.1186/s12913-024-10784-9.
5
Implementation of medication reviews in community pharmacy: reaching consensus on stakeholders' recommendations for mechanisms of change using the nominal group technique.在社区药房实施药物审查:使用名义群体技术就变革机制达成利益相关者建议的共识。
Int J Clin Pharm. 2024 Jun;46(3):714-726. doi: 10.1007/s11096-024-01708-y. Epub 2024 Mar 15.
6
An EHR-based method to structure, standardize, and automate clinical documentation tasks for pharmacists to generate extractable outcomes.一种基于电子健康记录的方法,用于构建、规范和自动化药剂师的临床文档任务,以生成可提取的结果。
JAMIA Open. 2023 May 11;6(2):ooad034. doi: 10.1093/jamiaopen/ooad034. eCollection 2023 Jul.
7
A cross-sectional study comparing emotional intelligence and perceived stress amongst community pharmacists delivering and not delivering a new service.一项横断面研究比较了提供和不提供新服务的社区药剂师的情绪智力和感知压力。
Int J Clin Pharm. 2023 Oct;45(5):1136-1143. doi: 10.1007/s11096-023-01542-8. Epub 2023 Feb 11.
8
Just a 'romantic idea'? A theory-based interview study on medication review implementation with pharmacy owners.只是“浪漫的想法”?基于理论的药店所有者药物审查实施访谈研究。
Int J Clin Pharm. 2023 Apr;45(2):451-460. doi: 10.1007/s11096-022-01524-2. Epub 2023 Jan 13.
9
Pharmacist-led clinical medication review service in primary care: the perspective of general practitioners.药剂师主导的初级保健临床药物审查服务:全科医生的观点。
BMC Prim Care. 2023 Jan 10;24(1):6. doi: 10.1186/s12875-022-01963-w.
10
Community pharmacy and general practice collaborative and integrated working: a realist review protocol.社区药房与全科医疗协作与整合工作:一个实际主义综述研究方案。
BMJ Open. 2022 Dec 29;12(12):e067034. doi: 10.1136/bmjopen-2022-067034.
利益相关者分析,旨在预防心血管疾病的社区药房服务的发展。
Res Social Adm Pharm. 2017 May-Jun;13(3):539-552. doi: 10.1016/j.sapharm.2016.06.009. Epub 2016 Jun 30.
4
A Systematic Review of Evidence-Based Community Pharmacy Services Aimed at the Prevention of Cardiovascular Disease.基于循证的旨在预防心血管疾病的社区药学服务的系统评价
J Manag Care Spec Pharm. 2016 Jun;22(6):699-713. doi: 10.18553/jmcp.2016.22.6.699.
5
Meta-synthesis of qualitative research: the challenges and opportunities.质性研究的元整合:挑战与机遇
Int J Clin Pharm. 2016 Jun;38(3):695-704. doi: 10.1007/s11096-016-0289-2. Epub 2016 Apr 6.
6
How to use the nominal group and Delphi techniques.如何使用名词组和德尔菲技术。
Int J Clin Pharm. 2016 Jun;38(3):655-62. doi: 10.1007/s11096-016-0257-x. Epub 2016 Feb 5.
7
Intervention mapping for developing pharmacy-based services and health programs: A theoretical approach.基于药房的服务和健康项目开发中的干预映射:一种理论方法。
Am J Health Syst Pharm. 2016 Feb 1;73(3):156-64. doi: 10.2146/ajhp150245.
8
Barriers to promote cardiovascular health in community pharmacies: a systematic review.社区药房促进心血管健康的障碍:一项系统综述。
Health Promot Int. 2017 Jun 1;32(3):535-548. doi: 10.1093/heapro/dav098.
9
Model for the evaluation of implementation programs and professional pharmacy services.实施计划与专业药学服务评估模型
Res Social Adm Pharm. 2016 May-Jun;12(3):515-22. doi: 10.1016/j.sapharm.2015.08.003. Epub 2015 Aug 15.
10
Development of a pharmacy practice intervention: lessons from the literature.药学实践干预措施的开发:文献中的经验教训。
Int J Clin Pharm. 2016 Jun;38(3):601-6. doi: 10.1007/s11096-015-0180-6. Epub 2015 Aug 22.